Signal transduction pathways in acute myetoid leukemia
Promotie: mw. L. Han, 13.15 uur, Academiegebouw, Broerstraat 5, Groningen
Proefschrift: Signal transduction pathways in acute myetoid leukemia
Promotor(s): prof.dr. E. Vellenga
Faculteit: Medische Wetenschappen
Contact: via de persvoorlichters van het UMCG, tel. 050-361 2200, e-mail: voorlichting bvl.umcg.nl
Signal transduction pathways in acute myetoid leukemia
Acute myeloid leukemia (AML) is characterized by the uncontrolled accumulation of abnormal white blood cells in the bone marrow that replace normal blood cells, including red blood cells, platelets and normal white blood cells. The symptoms include fatigue, shortness of breath, bleeding, and high risk of infection. Emerging studies consider that leukemic stem cells (LSCs) initiate and maintain AML, and their quiescent state contributes to resistance of chemotherapy. A number of abnormal signaling pathways have been identified in AML LSCs. A novel inhibitor dasatinib was demonstrated to be a potential inhibitor in a subgroup of AML.
| Last modified: | 13 March 2020 01.16 a.m. |
More news
-
05 March 2025
Women in Science
The UG celebrates International Women’s Day with a special photo series: Women in Science.
-
16 December 2024
Jouke de Vries: ‘The University will have to be flexible’
2024 was a festive year for the University of Groningen. In this podcast, Jouke de Vries, the chair of the Executive Board, looks back.
-
10 June 2024
Swarming around a skyscraper
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...